BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

Published:2011-10-19 Issue:10 Volume:6 Page:e25806
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

El-Osta Hazem,Falchook Gerald,Tsimberidou Apostolia,Hong David,Naing Aung,Kim Kevin,Wen Sijin,Janku Filip,Kurzrock Razelle

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. BRAF, a target in melanoma: implications for solid tumor drug development.;KT Flaherty;Cancer,2010

2. Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.;JC Rubinstein;J Transl Med,2010

3. Mutations of the BRAF gene in human cancer.;H Davies;Nature,2002

4. Safety and efficacy results from the first-in-human study of the oral MEK1/2 inhibitor GSK1120212.;JR Infante;J Clin Oncol,2010

5. Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors.;R Kefford;J Clin Oncol,2010

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system;Cancer Letters;2024-03

2. Prognostic Value of Baseline 18F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients;Cancers;2023-12-26

3. A review of recent advances in the molecular mechanisms underlying brain metastasis in lung cancer;Molecular Cancer Therapeutics;2023-12-20

4. BRAF/MEK Inhibition as a Bridge to Immunotherapy for Symptomatic BRAF V600 Melanoma Brain Metastases: A Case Series;Journal of the National Comprehensive Cancer Network;2023-10

5. Brain metastases of papillary thyroid carcinoma origin are derived from aggressive histologic variants and demonstrate similar adverse morphology in the metastatic lesion;Clinical Neurology and Neurosurgery;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3